Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

enGene Holdings Inc. Common Stock

ENGN
Current price
7.93 USD -0.17 USD (-2.10%)
Last closed 8.12 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 402 693 824 USD
Yield for 12 month -1.12 %
1Y
3Y
5Y
10Y
15Y
ENGN
21.11.2021 - 28.11.2021

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada. Address: 7171 Rue Frederick Banting, Saint-Laurent, QC, Canada, H4S 1Z9

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

30.57 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-175 000 USD

Last Year

Current Quarter

-82 000 USD

Last Quarter

-78 000 USD

Key Figures ENGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -54 995 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -22.07 %
PEG Ratio
Return On Equity TTM -123.06 %
Wall Street Target Price 30.57 USD
Revenue TTM
Book Value 5.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.79 USD
Diluted Eps TTM -2.79 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ENGN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ENGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:1
Payout Ratio
Last Split Date 01.11.2023
Dividend Date

Stock Valuation ENGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -6.0087
Price Book MRQ 1.7483

Financials ENGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ENGN

For 52 weeks

4.42 USD 18.4 USD
50 Day MA 7.52 USD
Shares Short Prior Month 498 542
200 Day MA 10.67 USD
Short Ratio 2.78
Shares Short 813 007
Short Percent 2.57 %